Comparison of Fasiglifam (TAK-875) to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Public ClinicalTrials.gov record NCT01549964. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of TAK-875 25 mg and 50 mg Compared to Placebo and Sitagliptin 100 mg When Used in Combination With Metformin in Subjects With Type 2 Diabetes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy of 2 doses of TAK-875 (25 mg and 50 mg), once daily (QD), plus metformin compared to placebo plus metformin and sitagliptin plus metformin on lowering blood sugar.
Study identification
- NCT ID
- NCT01549964
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 916 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2012 (Type not available)
- Primary completion
- Mar 2014 (Actual)
- Completion
- Mar 2014 (Actual)
- Last update posted
- Jun 2, 2016
2012 – 2014
United States locations
- U.S. sites
- 58
- U.S. states
- 24
- U.S. cities
- 58
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Muscle Shoals | Alabama | — | — |
| Not listed | Mesa | Arizona | — | — |
| Not listed | Peoria | Arizona | — | — |
| Not listed | Phoenix | Arizona | — | — |
| Not listed | Chula Vista | California | — | — |
| Not listed | El Cajon | California | — | — |
| Not listed | La Mesa | California | — | — |
| Not listed | Laguna Hills | California | — | — |
| Not listed | National City | California | — | — |
| Not listed | Paramount | California | — | — |
| Not listed | San Diego | California | — | — |
| Not listed | Stockton | California | — | — |
| Not listed | Tustin | California | — | — |
| Not listed | West Hills | California | — | — |
| Not listed | Trumbull | Connecticut | — | — |
| Not listed | Coral Gables | Florida | — | — |
| Not listed | Jacksonville | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | New Port Richey | Florida | — | — |
| Not listed | Ocala | Florida | — | — |
| Not listed | West Palm Beach | Florida | — | — |
| Not listed | Meridian | Idaho | — | — |
| Not listed | Chicago | Illinois | — | — |
| Not listed | Greenfield | Indiana | — | — |
| Not listed | Muncie | Indiana | — | — |
| Not listed | Lexington | Kentucky | — | — |
| Not listed | Owensboro | Kentucky | — | — |
| Not listed | Hyattsville | Maryland | — | — |
| Not listed | Troy | Michigan | — | — |
| Not listed | Picayune | Mississippi | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Haddon Heights | New Jersey | — | — |
| Not listed | Rosedale | New York | — | — |
| Not listed | Calabash | North Carolina | — | — |
| Not listed | Charlotte | North Carolina | — | — |
| Not listed | Monroe | North Carolina | — | — |
| Not listed | Morehead City | North Carolina | — | — |
| Not listed | Winston-Salem | North Carolina | — | — |
| Not listed | Cincinnati | Ohio | — | — |
| Not listed | Cleveland | Ohio | — | — |
| Not listed | Dayton | Ohio | — | — |
| Not listed | Norman | Oklahoma | — | — |
| Not listed | Lancaster | Pennsylvania | — | — |
| Not listed | Levittown | Pennsylvania | — | — |
| Not listed | Spartanburg | South Carolina | — | — |
| Not listed | Crossville | Tennessee | — | — |
| Not listed | Memphis | Tennessee | — | — |
| Not listed | Carrollton | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | Irving | Texas | — | — |
| Not listed | Katy | Texas | — | — |
| Not listed | McKinney | Texas | — | — |
| Not listed | Plano | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Spring | Texas | — | — |
| Not listed | Salt Lake City | Utah | — | — |
| Not listed | West Jordan | Utah | — | — |
| Not listed | Richmond | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 102 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01549964, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 2, 2016 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01549964 live on ClinicalTrials.gov.